Pharmacology, Toxicology and Pharmaceutical Science
Tablet
100%
Infliximab
95%
Pharmacokinetics
80%
Inflammatory Bowel Disease
78%
Normal Human
63%
Bioavailability
59%
Urea C 13
57%
Prematurity
52%
Gemcitabine
50%
Non Small Cell Lung Cancer
50%
Dosage Forms
45%
Trough Level
27%
Guanosine Phosphate
25%
Adsorption
25%
Cystic Fibrosis
25%
Drug Delivery System
25%
Angioneurotic Edema
25%
Breast Cancer
25%
Pilocarpine
25%
Cytidine Deaminase
25%
Parenteral Solution
25%
Clonidine
25%
Chronic Urticaria
25%
Hyperglycemia
25%
Community Pharmacy
25%
Venlafaxine
25%
Hot Flush
25%
Drug Delivery Device
25%
Hospital Pharmacy
25%
Epirubicin
25%
Adverse Event
25%
Infusion Fluid
25%
Side Effect
16%
Clinical Trial
12%
Infection
12%
Polypropylene
12%
Monoclonal Antibody
11%
Disease Activity
10%
Drug Release
8%
Carbon Dioxide
7%
Inulin
6%
Intravenous Therapy
6%
Oligosaccharide
6%
Crohn's Disease
6%
Ileum
5%
High Performance Liquid Chromatography
5%
Retrospective Study
5%
Pharmaceutical Technology
5%
Drug Antibody
5%
Keyphrases
Infliximab
75%
Inflammatory Bowel Disease
33%
Population Pharmacokinetic Model
30%
Population Pharmacokinetics
27%
Colon-specific
27%
Pediatric Inflammatory Bowel Disease
25%
External Evaluation
25%
Principle Calculation
25%
Colon Drug Delivery System
25%
Clinical Practice
25%
Disease Potential
25%
ColoPulse
25%
Chronic Spontaneous Urticaria
25%
Calcium Infusion
25%
Drug Compounding
25%
Impact Analysis
25%
Angioedema
25%
Assure
25%
Cystic Fibrosis
25%
Pilocarpine
25%
Intravenous System
25%
Pharmacy
25%
Sweat Test
25%
Trough Level
22%
HCl Solution
14%
Parenteral Solutions
12%
Pharmacokinetic Model
10%
Dose Optimization
7%
Local Delivery
6%
Monoclonal Antibody
6%
Crohn's Disease
6%
Climatic Zones
6%
Inulin
6%
Oligosaccharides
6%
Condition-dependent
6%
Sugar Glass
6%
Intravenous Therapy
6%
Pharmacopoeial Requirements
6%
Sampling Plan
6%
Aluminium Contamination
6%
Calcium Solution
6%
Shelf Stability
6%
Microbial Risk Assessment
6%
Insulin Adsorption
6%
Neonatal Hyperglycemia
6%
Bayesian Estimation
5%
Superior Performance
5%
Serum Samples
5%
Disease Activity Score
5%
Serum Trough Levels
5%